Adipokine update - New molecules, new functions

被引:16
|
作者
Gelsinger C. [1 ]
Tschoner A. [1 ]
Kaser S. [1 ]
Ebenbichler C.F. [1 ]
机构
[1] Universitätsklinik für Innere Medizin I, Department Innere Medizin, Medizinische Universität Innsbruck, 6020 Innsbruck Österreich
关键词
Adipokines; Diabetes; Inflammatory disease; Insulin resistance; Metabolic syndrome; Obesity; Visceral adipose tissue;
D O I
10.1007/s10354-010-0781-6
中图分类号
学科分类号
摘要
The prevalence of obesity is rising worldwide. Recent research findings show that adipose tissue is a highly active endocrine organ, which is involved in many physiological processes. These metabolic processes are influenced by products of the adipose tissue, so-called adipokines, which play a crucial role in the pathogenesis of the metabolic syndrome and cardiovascular disease. In addition, the two major fat depots - intraabdominal and subcutaneous - differ in their ability to secrete adipokines. In recent years the importance of the association between intraabdominal fat and the development of insulin resistance, diabetes mellitus type 2 and dyslipidemia was recognized. Therefore, accumulation of visceral adipose tissue contributes due to its ability to secrete a different pattern of adipokines to increased morbidity and mortality. This review aims to characterize novel, newly recognized adipokines and to discuss their roles in the pathogenesis of insulin resistance and atherosclerosis, as well as other metabolic complications. © Springer-Verlag 2010.
引用
收藏
页码:377 / 390
页数:13
相关论文
共 50 条
  • [1] Omentin - a new adipokine with many roles to play
    Halabis, Magdalena
    Dziedzic, Marcin
    Warchulinska, Joanna
    Kaznowska-Bystryk, Iwona
    Solski, Janusz
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2015, 28 (03) : 176 - 180
  • [2] New roles of the multidimensional adipokine: Chemerin
    Fatima, Syeda Sadia
    Rehman, Rehana
    Baig, Mukhtiar
    Khan, Taseer Ahmed
    PEPTIDES, 2014, 62 : 15 - 20
  • [3] Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension
    Korolczuk, Agnieszka
    Beltowski, Jerzy
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (10) : 1533 - 1539
  • [4] Update on new insulins
    Tapia Ceballos, L.
    ANALES DE PEDIATRIA, 2009, 70 (01): : 65 - 71
  • [5] New molecules implied in obesity and insulinoresistance: adipokines
    Aubert, R
    OCL-OLEAGINEUX CORPS GRAS LIPIDES, 2003, 10 (02): : 131 - 134
  • [6] Neuroendocrine control of energy homeostasis: update on new insights
    Kalra, Satya P.
    Kalra, Pushpa S.
    NEUROENDOCRINOLOGY: THE NORMAL NEUROENDOCRINE SYSTEM, 2010, 181 : 17 - 33
  • [7] Zinc-α2-Glycoprotein: Is There Association between This New Adipokine and Body Composition in Hemodialysis Patients?
    Leal, Viviane O.
    Lobo, Julie C.
    Stockler-Pinto, Milena B.
    Farage, Najla E.
    Velarde, Guillermo C.
    Fouque, Denis
    Leite, M., Jr.
    Mafra, Denise
    RENAL FAILURE, 2012, 34 (09) : 1062 - 1067
  • [8] Relationship between obesity, inflammation and insulin resistance:: new concepts.
    Feve, Bruno
    Bastard, Jean-Philippe
    Vidal, Hubert
    COMPTES RENDUS BIOLOGIES, 2006, 329 (08) : 587 - 597
  • [9] Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature
    Mazur-Bialy, Agnieszka Irena
    NUTRIENTS, 2021, 13 (02) : 1 - 10
  • [10] New Functions of Vav Family Proteins in Cardiovascular Biology, Skeletal Muscle, and the Nervous System
    Rodriguez-Fdez, Sonia
    Francisco Lorenzo-Martin, L.
    Fabbiano, Salvatore
    Menacho-Marquez, Mauricio
    Sauzeau, Vincent
    Dosil, Mercedes
    Bustelo, Xose R.
    BIOLOGY-BASEL, 2021, 10 (09):